REQUEST A DEMO
Total
USD $0.00
Search more companies

Wimba Poland Sp. z o.o. (Poland)

Main Activities: Medical Equipment and Supplies Manufacturing
Secondary Activities: All Other Information Services | Computer Systems Design and Related Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Veterinary Services
Full name: Wimba Poland Sp. z o.o. Profile Updated: February 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Wimba is a company providing innovative orthotic solutions for pets. They use 3D printing technology and advanced materials to create custom-made orthotics that are lightweight, durable, and tailored to each pet's specific needs. Wimba offers a range of orthotic devices, including tarsal and carpal braces, cervical collars, and prosthetics, claiming to serve over 200 customers in more than 20 countries. The company operates across 7 markets, including Europe, the US, and Australia.

Headquarters
Ul. Fabryczna 20A
Krakow; Malopolskie; Postal Code: 31-553

Contact Details: Purchase the Wimba Poland Sp. z o.o. report to view the information.

Website: http://wimba.pet

Basic Information
Registered Capital:
Purchase the Wimba Poland Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Wimba Poland Sp. z o.o. report to view the information.
Incorporation Date:
May 26, 2022
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Wimba Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
26.41%
Total operating revenue
27.46%
Operating Profit/Loss (EBIT)
-24.45%
EBITDA
-25.6%
Net Profit/Loss for the Period
-50.78%
Total Assets
139.78%
Total Equity
N/A
Operating Profit Margin (ROS)
1.71%
Net Profit Margin
-20.62%
Return on Equity (ROE)
N/A
Quick Ratio
3.08%
Cash Ratio
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?